ORIGINAL RESEARCH article
Front. Surg.
Sec. Genitourinary Surgery and Interventions
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1702376
Clinical Application of Enhanced Recovery After Surgery in Bipolar Transurethral Vaporization of Prostate for Benign Prostatic Hyperplasia
Provisionally accepted
Xinliang Cai1
Yuan Yuan1Lin Jiang1Yifei Zhu1Ruidong Ji1Mingchi Wang1Ruixi Tang1
Zhenquan Lu1*
Bingfeng Luo1,2*- 1The University of Hong Kong-Shenzhen Hospital, Shenzhen, China
- 2The First Clinical Medical College of Jinan University, Guangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Objective: To explore the clinical application of enhanced recovery after surgery (ERAS) in bipolar transurethral vaporization of the prostate (B-TUVP) and its impact on postoperative recovery. Methods: A retrospective analysis was conducted on the clinical data of 212 patients with benign prostatic hyperplasia (BPH) admitted to the Department of Urology of our hospital from January 2019 to December 2024. Among them, 121 patients were managed under an ERAS protocol (ERAS group), and 91 patients received traditional perioperative care (control group). The clinical characteristics included age, mean body mass index (BMI), preoperative comorbidities, prostate volume (PV), preoperative International Prostate Symptom Score (IPSS), preoperative Quality of Life (QoL) score, preoperative urinary flow rate, and urodynamic parameters. Preoperative management, intraoperative management, and postoperative outcomes were compared between the two groups. Results: The clinical baseline data showed no significant differences between the two groups. Compared with the control group, the ERAS group had a significantly shorter duration of continuous bladder irrigation, time to first ambulation, and postoperative length of stay (P < 0.001). The total hospitalization costs were also significantly lower in the ERAS group compared to the control group (P < 0.01). There was no significant difference in the incidence of postoperative complications between the two groups. Conclusion: The application of the ERAS protocol in B-TUVP can promote postoperative recovery, reduce the postoperative length of stay, and decrease total hospitalization costs. However, more prospective randomized controlled trials are needed to further validate the feasibility and effectiveness of this protocol.
Keywords: Enhanced recovery after surgery, bipolar transurethral vaporization of the prostate, Length of Stay, Hospitalization costs, Postoperative Complications
Received: 16 Sep 2025; Accepted: 06 Oct 2025.
Copyright: © 2025 Cai, Yuan, Jiang, Zhu, Ji, Wang, Tang, Lu and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zhenquan Lu, luzq@hku-szh.org
Bingfeng Luo, luobf@hku-szh.org
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.